UNSPSC 51141584: Valpromide

This classification denotes an anticonvulsant and valproic acid analog with the molecular formula C8H17NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RUA6CWU76G, chemically known as valeramide, 2-propyl- but generally known as valpromide, which bears US NIH Compound Identifier 71113. European Medicines Agency schedules Valpromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00016MIG. World Health Organization schedules valpromide in its Anatomical Therapeutic Chemical (ATC) Classification.

VALPROMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule valpromide under HS 29241900 and SITC 51471. As of Q4 2014, VALPROMIDE remains the US FDA Preferred Term for this commodity. SMILES: O=C(N)C(CCC)CCC.

UNSPSC 51141584 Valpromide is a Commodity code that nominally refers to a specific pharmaceutical compound, but recent state and local procurement activity under this code shows a significant mismatch. Seminole County, Florida posted an IFB (IFB60459723LAS) in June 2026 for Naloxone and Safe Drug Deactivation Systems — opioid-overdose reversal medication and drug disposal equipment — rather than valpromide itself. The procurement seeks 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive bidding to support community health initiatives, with quarterly deliveries required to the Seminole County Community Health Building in Sanford, Florida. The contract carries a two-year initial term with a one-year renewal option, fixed-fee pricing, and standard compliance requirements including drug-free workplace certification, E-Verify authorization, and potential FEMA-related federal regulations. Vendors must include all shipping and delivery costs in their proposals and carry workers' compensation, commercial general liability, and professional liability insurance.

The code shows limited recent activity under its stated scope — only one documented opportunity in the recent-opportunities block. Seminole County, a large Florida county government, is the sole issuing body represented. The IFB posted June 30, 2026 carried a response deadline of July 26, 2023, which represents a date inconsistency in the source material itself. The procurement does not specify set-aside designations for disadvantaged enterprises and does not explicitly state a total contract value. Given the divergence between the code's pharmaceutical name and the actual goods being procured (overdose-reversal and drug-disposal equipment rather than valpromide), this code may not reliably predict future state and local purchasing activity aligned with the code's nominal definition.